Tag: pharmacology


  • Opioid receptors in motion: new clues for safer painkillers

    Opioid receptors in motion: new clues for safer painkillers

    Understanding the moving target: mu-opioid receptors For decades, scientists have known that opioids relieve pain by binding to mu-opioid receptors in the brain. These molecular switches, when activated, set off a cascade of signals that dull the perception of pain. But the exact sequence of events inside the receptor remained murky. A recent wave of…

  • Personalized TAMENDOX Therapy Boosts Tamoxifen Effectiveness in Early Breast Cancer

    Personalized TAMENDOX Therapy Boosts Tamoxifen Effectiveness in Early Breast Cancer

    Introduction: A new twist in tamoxifen treatment Breast cancer remains the most commonly diagnosed cancer among women worldwide. In a decisive step toward more effective hormone therapy, the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) has unveiled TAMENDOX, a personalized treatment strategy designed to optimize tamoxifen’s impact for individual patients. This multicenter clinical study…

  • New Personalized Therapy Boosts Tamoxifen Effectiveness in Breast Cancer Patients

    New Personalized Therapy Boosts Tamoxifen Effectiveness in Breast Cancer Patients

    Overview Breast cancer remains the most common cancer among women worldwide. Recent advances from the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) introduce a new personalized therapy, TAMENDOX, designed to tailor hormone treatment to individual patients. The goal is to improve the effectiveness of tamoxifen, a long-standing drug used to treat hormone-dependent breast cancer,…

  • New Class of Painkillers Aims to Ease Pain Without Suppressing Inflammation

    New Class of Painkillers Aims to Ease Pain Without Suppressing Inflammation

    Rethinking Pain Relief: A Targeted Approach Current painkillers, notably non-steroidal anti-inflammatory drugs (NSAIDs), fight pain by dampening inflammation. While effective, this approach can delay healing and increase the risk of side effects affecting the heart, stomach, kidneys, and liver. A new line of research from the University of Florence promises a different path: severing the…

  • New Painkillers Could Separate Pain Relief from Inflammation: A Potential Breakthrough

    New Painkillers Could Separate Pain Relief from Inflammation: A Potential Breakthrough

    Rewriting Pain Management: A New Strategy Emerges Current non-steroidal anti-inflammatory drugs (NSAIDs) are effective at easing pain by blocking prostaglandins — chemicals involved in inflammation. While this helps reduce discomfort, it can also hinder the body’s healing processes and bring a range of side effects, from stomach issues to heart and kidney risks. A recent…

  • New Painkillers Target Pain Without Blocking Healthy Inflammation

    New Painkillers Target Pain Without Blocking Healthy Inflammation

    Overview: A Shift in Pain Management Current painkillers, especially non-steroidal anti-inflammatory drugs (NSAIDs), are effective at dulling pain but often come with a trade-off: they blunt inflammation, a critical part of the body’s healing process. A new line of research conducted by pharmacologists and clinicians from the University of Florence in Italy investigates a strategy…

  • Older Adults in Nursing Homes Face Higher Seizure Risk With Tramodol and Some Antidepressants

    Older Adults in Nursing Homes Face Higher Seizure Risk With Tramodol and Some Antidepressants

    New Findings on Drug Interactions in Senior Care A study published on October 8, 2025, in Neurology®, the medical journal of the American Academy of Neurology, reports a modest but meaningful link between taking tramadol for pain and certain antidepressants that inhibit the CYP2D6 enzyme in older adults living in nursing homes. The researchers found…